CJC-1295 + 伊帕瑞林混合 (CJC-1295 + Ipamorelin Blend)

"Our neuroendocrinology lab at a pharmaceutical research facility has been using LyzeLabs CJC-1295 + Ipamorelin Blend for synergistic GH secretion research for 9 months. The dual-pathway amplification is exceptional - our primary rat pituitary cell assays consistently show 11-14x GH release (ELISA quantification) compared to 4.5x for CJC-1295 alone or 5.8x for Ipamorelin alone, confirming true synergistic supraadditivity from cAMP-PKA and calcium pathway convergence. We independently verified >98% purity for both components via HPLC (two distinct peaks with proper retention times) and mass spec confirmed molecular weights (CJC-1295: 3367.3 Da, Ipamorelin: 711.4 Da). The pre-formulated blend eliminates mixing variability we encountered when administering separate peptides - batch-to-batch GH secretion reproducibility improved dramatically (CV <8% across 12 experiments vs >18% with manual mixing). We measured dual receptor activation: cAMP accumulation assays show robust GHRH-R Gs signaling, calcium imaging demonstrates GHS-R1a Gq activation with IP3-mediated calcium release, and the convergence produces supraadditive GH vesicle exocytosis. Mechanistically, we used PKA inhibitors (H-89) and calcium chelators (BAPTA-AM) confirming synergy requires both pathways intact - blocking either reduces GH to single-pathway levels. The selectivity of Ipamorelin is valuable - no appetite stimulation (unlike GHRP-6), minimal cortisol elevation (unlike GHRP-2), enabling clean GH studies without confounding metabolic effects. Delivery to Berlin takes 10-12 days with proper cold-chain packaging. The CP10 specification is perfect for our multi-week dual-pathway protocols. This is the gold standard combination secretagogue formulation for GH research internationally."

2025-11-13

"Smooth from order to door. Answered on WhatsApp within the hour."

2025-11-10

"Held up in testing. Reordering without a second thought."

2025-11-07